Karl Storz Endoscopy-America, Inc. v. Fiber Tech Medical, Inc.

4 F. App'x 128
CourtCourt of Appeals for the Fourth Circuit
DecidedFebruary 5, 2001
Docket00-1032
StatusUnpublished
Cited by1 cases

This text of 4 F. App'x 128 (Karl Storz Endoscopy-America, Inc. v. Fiber Tech Medical, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Karl Storz Endoscopy-America, Inc. v. Fiber Tech Medical, Inc., 4 F. App'x 128 (4th Cir. 2001).

Opinion

OPINION

PER CURIAM.

I.

This appeal arises from an action for trademark infringement and false designation of origin under sections 32(l)(a) and 43(a) of the Lanham Trade-Mark Act, 15 U.S.C. §§ 1114(l)(a) and 1125(a). Appellant Karl Storz Endoscopy-America (“KSEA”) is the exclusive United States distributor for Karl Storz rigid endoscopes. Appellee Fiber Tech Medical, Inc. (“Fiber Tech”), a subsidiary of GE Medical Systems, Inc., repairs and rebuilds damaged rigid endoscopes, including endoscopes of Karl Storz origin, for their owners.

KSEA sought to enjoin Fiber Tech from providing these repair services within the United States based on its concern that the repaired or rebuilt Karl Storz rigid endoscopes may be mistaken by surgeon users for genuine Karl Storz products and thus might injure, trade upon, or appropriate the reputation and goodwill of KSEA and the Karl Storz brand. The district court granted Fiber Tech’s motion for summary judgment, finding that the activities at issue did not constitute “use in commerce” and were, therefore, not actionable under the Lanham Act. We now affirm that opinion.

Rigid endoscopes typically are owned by hospitals. It is the hospitals that ordinarily send damaged rigid endoscopes directly to Fiber Tech for repair. The surgeons are, however, the end-users of these instruments. It is, therefore, the surgeons who generally make judgments as to the quality and performance characteristics of the endoscopes, and who greatly influence, if not dictate, purchasing decisions for these instruments.

Fiber Tech provides the hospitals with complete disclosure of the extent of the repairs made. This disclosure is included on paperwork returned to the hospital, in duplicate. The documentation contains a written request that the end-user be provided with a copy of the documentation of the repair. For present purposes, it is presumed that the actual end-users, the surgeons, do not receive the paperwork. KSEA has also presented evidence that surgeons have, in fact, been confused as to whether they were using an original or rebuilt endoscope.

Accepting the facts stated above as true, the district court granted Fiber Tech’s motion for summary judgment based on its conclusion that there was no “use in commerce” as required under the relevant sections of the Lanham Act. The district court held, in critical part, that the Lanham Act requires a “sale to a third party,” and Fiber Tech’s activities did not, as a matter of law, constitute a sale. Rather, Fiber Tech’s activities constituted repair or reconditioning, which is outside the purview of the Act. The validity of this conclusion *130 of the district court is the only issue on appeal.

II.

This court reviews the district court’s grant of summary judgment de novo. Brown & Williamson Tobacco Corp. v. Food & Drug Admin., 153 F.3d 155, 160 (4th Cir.1998). All justifiable factual inferences are drawn in favor of plaintiff-appellant, KSEA:

The standard that an appellate court applies in reviewing an order which grants summary judgment is the same as that which governs the district court’s initial action under Fed.R.Civ.P. 56(c). Summary judgment is proper where there is no genuine issue as to any material fact and the moving party is entitled to judgment as a matter of law. The facts, and the inferences to be drawn from the facts, must be viewed in the light most favorable to the party opposing the motion.

Ballinger v. North Carolina Agric. Extension Serv., 815 F.2d 1001, 1004 (4th Cir. 1987) (citations omitted). Issues of statutory construction are reviewed de novo. See, e.g., United States v. Linney, 134 F.3d 274, 282 (4th Cir.1998).

For present purposes, therefore, this court accepts the following as true: (1) the delicate and highly sensitive use of rigid endoscopes and the surgeon-users’ reliance on their accuracy and consistency; (2) KSEA’s extensive investment in building its name and reputation for reliability and accuracy; (3) the extent of Fiber Tech’s activities in remanufacturing rigid endoscopes, which, upon completion bear only KSEA;s trademarks and trade dress and display no indication of the fact or extent of Fiber Tech’s repair or rebuilding; (4) the inability of surgeon-users of the rebuilt endoscopes to visibly identify these instruments as having been modified or rebuilt by Fiber Tech; and (5) the ease with which Fiber Tech could identify itself, rather than KSEA, as the repairer-re-builder of the non-genuine instruments.

III.

KSEA sought relief below under section 32(l)(a) (15 U.S.C. § 1114(l)(a)) and section 43(a) (15 U.S.C. § 1125(a)) of the Lanham Act. Section 32 provides that:

Any person who shall, without the consent of the registrant—
(a) use in commerce any reproduction, counterfeit, copy, or colorable imitation of a registered mark in connection with the sale, offering for sale, distribution, or advertising of any goods or services on or in connection with which such use is likely to cause confusion, or to cause mistake, or to deceive ... shall be liable in a civil action by the registrant for the remedies hereinafter provided.

15 U.S.C. § 1114(l)(a).

Section 43(a) of the Act creates a cause of action against any person who misuses a mark in a manner that is likely to cause confusion, and extends this protection to unregistered marks as well as registered marks and to “any false designation or origin”:

Any person who, on or in connection with any goods or services ... uses in commerce any word, term, symbol or device, ... or any combination thereof, or any false designation of origin, ... which—
(A) is likely to cause confusion, or to cause mistake, or to deceive, as to the affiliation, connection, or association of such person with another person, or as to the origin, sponsorship, or approval of his or her goods, services or commercial activities by another person
*131 shall be liable in a civil action by any person who believes that he or she is or is likely to be damaged by such act.

15 U.S.C. § 1125(a)(1).

In the present case, Fiber Tech has not copied a trademark but has modified a product bearing an existing, true, trademark. It is undisputed that leaving the original marks intact can itself constitute trademark infringement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Checkpoint Fluidic Systems International, Ltd. v. Guccione
888 F. Supp. 2d 780 (E.D. Louisiana, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
4 F. App'x 128, Counsel Stack Legal Research, https://law.counselstack.com/opinion/karl-storz-endoscopy-america-inc-v-fiber-tech-medical-inc-ca4-2001.